admin

Reviewed by Emily Henderson, B.Sc.Aug 13 2020 Eric Ross and Sean Cascarina, biochemistry and molecular biology researchers at Colorado State University, have released a research paper identifying a protein encoded by SARS-CoV-2, the virus that causes COVID-19, that may be associated with the quick spread of the virus through cells in the human body. Through
0 Comments
Print this page London, 6 August 2020 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) approved Dovato (dolutegravir/lamivudine) as a complete regimen for the treatment of HIV-1 infection to replace the current antiretroviral (ARV)
0 Comments
Reviewed by Emily Henderson, B.Sc.Aug 13 2020 Progress against DIPG, a fatal childhood brain tumor, is usually a game of inches. Studies that hint at even small gains are cause for celebration. That’s why researchers at the University of Michigan and their collaborators are excited about discoveries that point toward a new potential treatment approach
0 Comments
Moms who are COVID-19 positive when they deliver their babies can still breastfeed, say researchers. Although breastfeeding is highly recommended, mothers with the infection may be worried that nursing may pass the virus on to their child.  But a recent study published in the journal The Lancet Child and Adolescent Health said that if mothers follow correct hygienic practices, they are unlikely
0 Comments
It’s hard to deny that technology advances are improving the lives of people with diabetes worldwide. From smart insulin pumps that integrate with continuous glucose monitors (CGMs) to various applications with predictive features and alarms, the diabetes tech world continues to evolve rapidly. One company, January.ai, has recently announced its new artificial intelligence (AI) platform
0 Comments
The US Food and Drug Administration (FDA) has approved viltolarsen (Viltepso, NS Pharma), the second drug therapy for Duchenne muscular dystrophy in patients with a confirmed mutation amenable to exon 53 skipping. The FDA approved golodirsen (Vyondys 53, Sarepta Therapeutics) for this indication last year, as reported by Medscape Medical News.   “The FDA is
0 Comments
President Donald Trump said Wednesday the federal government is sending 125 million reusable face masks to school districts across the United States as schools consider whether it’s safe to reopen this fall amid the coronavirus pandemic. “We have to open up our schools and open up our businesses,” Trump said during a White House press
0 Comments
Print this page SOUTH SAN FRANCISCO, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) – Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that its COVID-19 Investigational New Drug (IND) application has been filed with the US Food and Drug Administration (FDA). “We are very excited to reach this
0 Comments
FDA Approves Viltepso (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy Print this page PARAMUS, N.J., Aug. 12, 2020 /PRNewswire/ — NS Pharma, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved Viltepso (viltolarsen) injection for patients with Duchenne muscular dystrophy (DMD) who
0 Comments
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans. Inhibition of miR-92a has shown beneficial effects in animal models, including improved vascularization after myocardial infarction, and accelerated wound healing, according to the peer-reviewed journal Nucleic Acid Therapeutics. “Based on documented, promising therapeutic potential, locked nucleic
0 Comments
The investigational, non-stimulant ADHD treatment SPN-812 (viloxazine extended-release capsules) met its primary endpoint in a pivotal phase III study, showing a significant improvement in symptoms in children ages 6 to 11. (Clinical Therapeutics) Although Kundalini yoga appeared to curb anxiety in adults, it wasn’t quite on par with cognitive behavioral therapy in a randomized trial.
0 Comments
The coronavirus pandemic has changed the fabric of our lives the world over. Many have lost their jobs and their livelihoods. Frankly, it’s a dark time. On the bright side, we’re learning more about the coronavirus every day, and the promise of a vaccine brings us hope. An end to our quarantined lives.   Many
0 Comments
Patients with sarcoidosis have an increased risk of heart failure and other adverse outcomes, including all-cause mortality, according to a decade-long nationwide study of Danish patients with the inflammatory disease. “Although these findings are suggestive of the need for regular monitoring of cardiac manifestations in patients with sarcoidosis, it is important to emphasize that no
0 Comments
This content originally appeared on diaTribe. Republished with permission. By Eliza Skoler As COVID restrictions and recommendations shift, what do we know about staying safe with diabetes? How can we protect others and make careful decisions about risk? As the pandemic continues to unfold, states and countries are leading their own initiatives to reduce infection
0 Comments
Following the success of their inaugural wellbeing festival in May, the Live Life Well Virtual Weekender returns from 11-13 September Over 30 expert speakers, campaigners and professionals will come together for the Live Life Well Virtual Weekender 2.0 this September, and Happiful are delighted to share that we’ll be supporting this amazing initiative once again,
0 Comments